Health, Longevity & Biohacking
Zuckerberg Predicts Virtual Cell Model Will Enable Digital Trials Within Five Years
No Priors Podcast
Biohub: The Future of Biology is Open-Source with Co-Founders Mark Zuckerberg, Priscilla Chan, and Head of Science Alex Rives
"If you can make it so that the groups of patients can come together and organize and say, hey, we would take an experimental drug on this, then it actually makes the economics make a lot more sense. If you can generate something more easily and you can pair it with a group of people, you can flip the cost structure."
Mark Zuckerberg outlined a vision where virtual cell models could fundamentally change drug development by allowing digital clinical trials and dramatically reducing the $1.5 billion, 15-year timeline for bringing drugs to market. He suggested that patient-organized trials combined with computational biology could enable experimental treatments to reach people faster, particularly for rare diseases where traditional economics don't work.
From this episode
No Priors Podcast